by Lance Smith | Jan 5, 2020 | Study Scavenger Clinical Trial Recruitment Platform
CUPERTINO, Calif., Jan. 2, 2020 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced the results from its Phase 2a clinical trial of DUR-928 in patients with mild to moderate plaque psoriasis. Twenty-two patients completed the study, applying DUR-928...by Lance Smith | Dec 31, 2019 | Study Scavenger Clinical Trial Recruitment Platform
A study published today in STEM CELLS Translational Medicine indicates that treating cryptoglandular perianal fistula with autologous adipose-derived stem cells (ASCs) is safe and can in fact promote long-term and sustained healing. The FISPAC Collaborative Group A...by Lance Smith | Dec 31, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Pivotal Phase 2/3 study is being conducted in collaboration with Children’s Oncology Group DUBLIN, Dec. 30, 2019 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in the pivotal Phase 2/3...by Lance Smith | Dec 31, 2019 | Study Scavenger Clinical Trial Recruitment Platform
A newly approved Chinese drug for Alzheimer’s will start clinical trials in the US and Europe next year as the country’s first novel therapy for the incurable disease seeks global legitimacy. Shanghai Green Valley Pharmaceutical Co. plans to recruit around 2,046...by Lance Smith | Dec 31, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Santa Ana, CA — (SBWIRE) — 12/30/2019 — Technological advancements have allowed medicial sciences to flourish. More and more studies are being conducted on a daily basis to discover novel ways of preventing, detecting, diagnosing, controlling, and...by Lance Smith | Dec 31, 2019 | Study Scavenger Clinical Trial Recruitment Platform
INDIANAPOLIS, Dec. 30, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the opening of the LIBRETTO-531 clinical trial [NCT04211337] for selpercatinib, also known as LOXO-292, for treatment-naïve RET-mutant medullary thyroid cancer (MTC)...